Stockscreener 앱 받기
0.00
100.00%
-8.61
전일 마감가:
$8.61
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$391.22M
수익:
$84.82M
순이익/손실:
$-21.43M
주가수익비율:
0.00
EPS:
-0.49
순현금흐름:
$-27.23M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$8.61
52주 변동 폭
$0.00
$16.11
Y Mabs Therapeutics Inc Stock (YMAB) Company Profile
명칭
Y Mabs Therapeutics Inc
전화
646-885-8505
주소
202 CARNEGIE CENTER, PRINCETON, NY
YMAB을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
YMAB
Y Mabs Therapeutics Inc
|
0.00 | 391.22M | 84.82M | -21.43M | -27.23M | -0.49 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Y Mabs Therapeutics Inc Stock (YMAB) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-22 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-11-18 | 개시 | Oppenheimer | Outperform |
| 2024-08-16 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-06-28 | 개시 | Truist | Buy |
| 2023-05-10 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2023-04-03 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-01-27 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2023-01-05 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-12-02 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-10-31 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2022-10-31 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-24 | 개시 | BMO Capital Markets | Outperform |
| 2022-02-03 | 재개 | Guggenheim | Buy |
| 2021-11-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-11-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-04-23 | 재개 | Cowen | Outperform |
| 2021-03-22 | 재개 | JP Morgan | Overweight |
| 2021-01-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-05-05 | 개시 | Barclays | Overweight |
| 2020-05-01 | 개시 | Janney | Buy |
| 2020-04-29 | 개시 | Morgan Stanley | Equal-Weight |
| 2019-12-24 | 개시 | JP Morgan | Overweight |
| 2019-11-20 | 개시 | Guggenheim | Buy |
| 2019-09-04 | 개시 | Wedbush | Outperform |
| 2019-04-01 | 개시 | H.C. Wainwright | Buy |
| 2018-10-16 | 개시 | BTIG Research | Buy |
| 2018-10-16 | 개시 | BofA/Merrill | Buy |
모두보기
Y Mabs Therapeutics Inc 주식(YMAB)의 최신 뉴스
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Receives Consensus Recommendation of "Reduce" from Brokerages - MarketBeat
Y-mAbs drops as Bank of America downgrades on headwinds to Danyelza - MSN
Jacobs Levy Equity Management Inc. Grows Holdings in Y-mAbs Therapeutics, Inc. $YMAB - MarketBeat
Y-Mabs Therapeutics, Inc. Announces Resignation of Peter Pfreundschuh as Chief Financial Officer, Effective September 16, 2025 - MarketScreener
Y-Mabs Therapeutics, Inc. Announces Resignation of Michael Rossi as Chief Executive Officer, Effective September 16, 2025 - MarketScreener
Y-Mabs Therapeutics Completes Merger with Perseus BidCo - TipRanks
Merger Talk: Is Y mAbs Therapeutics Inc. impacted by rising ratesTrade Risk Assessment & Capital Protection Trading Alerts - خودرو بانک
SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics - The Manila Times
SERB Pharmaceuticals Completes Acquisition of Y-mAbs Therapeutics - Benzinga
Technical Analysis: Should I hold or sell Y mAbs Therapeutics Inc nowJobs Report & Long Hold Capital Preservation Tips - خودرو بانک
Shorts Report: Is Massimo Group being accumulated by smart moneyWeekly Trade Analysis & Entry and Exit Point Strategies - خودرو بانک
Earnings Report: Is Y mAbs Therapeutics Inc. stock risky to hold nowWeekly Trade Summary & High Accuracy Investment Entry Signals - خودرو بانک
Ideas Watch: Will Y mAbs Therapeutics Inc outperform tech stocksQuarterly Trade Review & Free Risk Controlled Daily Trade Plans - خودرو بانک
Market Fear: Is Y mAbs Therapeutics Inc showing insider buyingJuly 2025 Gainers & Expert Verified Movement Alerts - خودرو بانک
Breakout Move: Is Y mAbs Therapeutics Inc backed by strong institutional buyingJuly 2025 Sector Moves & Weekly Chart Analysis and Guides - خودرو بانک
Y-mAbs Therapeutics, Inc.(NasdaqGS: YMAB) dropped from S&P TMI Index - MarketScreener
Aug Wrap: Is Y mAbs Therapeutics Inc stock overvalued or fairly pricedQuarterly Investment Review & Scalable Portfolio Growth Methods - خودرو بانک
Will Y mAbs Therapeutics Inc outperform tech stocksJuly 2025 Spike Watch & Comprehensive Market Scan Insights - خودرو بانک
Market Catalysts: Is Y mAbs Therapeutics Inc part of any ETFTreasury Yields & Real-Time Chart Breakout Alerts - خودرو بانک
Cubist Systematic Strategies LLC Has $689,000 Stock Position in Y-mAbs Therapeutics, Inc. $YMAB - MarketBeat
Short Interest in Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Decreases By 25.6% - MarketBeat
Nuveen LLC Makes New Investment in Y-mAbs Therapeutics, Inc. $YMAB - MarketBeat
Can Y mAbs Therapeutics Inc. be the next market leaderExit Point & Intraday High Probability Alerts - beatles.ru
Real time breakdown of Y mAbs Therapeutics Inc. stock performancePortfolio Return Summary & Expert Approved Trade Ideas - Newser
Sector ETF performance correlation with Y mAbs Therapeutics Inc.Weekly Trade Report & Safe Capital Growth Plans - Newser
Can Y mAbs Therapeutics Inc. stock double in the next yearEarnings Overview Summary & High Accuracy Trade Signal Alerts - خودرو بانک
CEO Moves: Should I trade or invest in Y mAbs Therapeutics Inc.July 2025 Rallies & Free Real-Time Market Sentiment Alerts - خودرو بانک
Aug Catalysts: Should I invest in Y mAbs Therapeutics Inc. before earningsWeekly Trade Report & Fast Gain Swing Trade Alerts - خودرو بانک
Chart based exit strategy for Y mAbs Therapeutics Inc.Quarterly Earnings Report & Weekly Sector Rotation Insights - Newser
Is Y mAbs Therapeutics Inc. stock risky to hold nowMarket Weekly Review & Accurate Buy Signal Notifications - خودرو بانک
Y-mAbs Therapeutics, Inc. $YMAB Shares Bought by Wellington Management Group LLP - MarketBeat
How to escape a deep drawdown in Y mAbs Therapeutics Inc.Market Trend Review & Weekly Hot Stock Watchlists - Newser
Published on: 2025-09-04 23:05:35 - Newser
Can Y mAbs Therapeutics Inc. disrupt its industryEarnings Recap Report & AI Enhanced Trading Signals - خودرو بانک
Custom strategy builders for tracking Y mAbs Therapeutics Inc.Breakout Watch & Daily Chart Pattern Signal Reports - Newser
Exit strategy if you’re trapped in Y mAbs Therapeutics Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - Newser
Can volume confirm reversal in Y mAbs Therapeutics Inc.July 2025 PreEarnings & Accurate Intraday Trade Tips - Newser
Intraday pattern recognizer results for Y mAbs Therapeutics Inc.Trade Risk Summary & Weekly High Potential Alerts - Newser
Is Y mAbs Therapeutics Inc. impacted by rising ratesGlobal Markets & Trade Opportunity Analysis - خودرو بانک
Acorn Capital Advisors LLC Raises Stake in Y-mAbs Therapeutics, Inc. $YMAB - MarketBeat
Will Y mAbs Therapeutics Inc. stock go up soonBull Run & Daily Stock Momentum Reports - Newser
Detecting support and resistance levels for Y mAbs Therapeutics Inc.Dip Buying & Stepwise Trade Signal Implementation - Newser
Signal strength of Y mAbs Therapeutics Inc. stock in tech scannersWeekly Market Report & Weekly High Conviction Trade Ideas - Newser
Is Y mAbs Therapeutics Inc. trading at a discountJuly 2025 Movers & Fast Gaining Stock Strategy Reports - khodrobank.com
Tools to monitor Y mAbs Therapeutics Inc. recovery probabilityTrade Risk Assessment & Free Daily Entry Point Trade Alerts - Newser
Custom watchlist performance reports with Y mAbs Therapeutics Inc.July 2025 Levels & Safe Capital Investment Plans - Newser
Does Y mAbs Therapeutics Inc. fit your quant trading modelJuly 2025 Setups & Safe Swing Trade Setup Alerts - Newser
Y Mabs Therapeutics Inc (YMAB) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
1.53%
자본화:
|
볼륨(24시간):